13F-HR filed by M28 Capital Management LP
M28 Capital Management LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-13, with 9 holding rows worth $137,568,801.
- Accession
- 0000902664-26-000993
- Filer
- CIK 1807489
- Filed
- 2026-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 9 entries on the cover page, a total value of $137,568,801 stated on the cover page (in dollars after the unit check, H1), rows summing to $137,568,801 with VALUE read as dollars as filed, 13F file number 028-21846. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 5,664,548 | $96,297,316 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 9,248,250 | $22,843,178 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 161,600 | $4,817,296 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 67,400 | $4,474,686 | dollars as filed | |
| FRACTYL HEALTH INC | 35168W103 | COM | 1,856,117 | $4,083,457 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 1,019,498 | $2,059,386 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 385,680 | $1,353,737 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 185,100 | $1,125,408 | dollars as filed | |
| CURIS INC | 231269309 | COM | 521,059 | $514,337 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000902664-26-000993 | this filing | 2026-02-13 | acceptance time not in the bulk data set |